Jun 2022

Business Combination with SoftBank-Sponsored SVF Investment Corp.
Capital Markets Advisor
View Details >May 2022

Sale of GeneDx, Inc., a Subsidiary of OPKO Health, Inc. (NASDAQ: OPK) to Sema4 Holdings Corp. (SMFR)
Financial Advisor
View Details >Feb 2021
$288 Million
Novus Capital Corporation II